메뉴 건너뛰기




Volumn 32, Issue 2, 2006, Pages 288-296

Medication-free research in early episode schizophrenia: Evidence of long-term harm?

Author keywords

First episode; Meta analysis; Psychosis; Spontaneous remission; Subgroup; Subtype

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

EID: 33645216314     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbj019     Document Type: Article
Times cited : (39)

References (87)
  • 1
    • 0028070548 scopus 로고
    • The continuing unethical use of placebo controls
    • Rothman KJ, Michels KB. The continuing unethical use of placebo controls. New Engl J Med 1994;331:394-398.
    • (1994) New Engl J Med , vol.331 , pp. 394-398
    • Rothman, K.J.1    Michels, K.B.2
  • 2
    • 0031036209 scopus 로고    scopus 로고
    • Research in schizophrenia and the discontinuation of antipsychotic medications
    • Wyatt RJ. Research in schizophrenia and the discontinuation of antipsychotic medications. Schizophr Bull. 1997;23:3-9.
    • (1997) Schizophr Bull , vol.23 , pp. 3-9
    • Wyatt, R.J.1
  • 3
    • 33645210789 scopus 로고    scopus 로고
    • At issue: Medication-free intervals and schizophrenia research - Editors' introduction
    • Shore D, Hsiao JK. At issue: medication-free intervals and schizophrenia research - editors' introduction. Schizophr Bull 1997;23:1.
    • (1997) Schizophr Bull , vol.23 , pp. 1
    • Shore, D.1    Hsiao, J.K.2
  • 4
    • 0343118718 scopus 로고    scopus 로고
    • The risk of medication-free research
    • Carpenter WT. The risk of medication-free research. Schizophr Bull. 1997;23:11-18.
    • (1997) Schizophr Bull , vol.23 , pp. 11-18
    • Carpenter, W.T.1
  • 5
    • 0035922432 scopus 로고    scopus 로고
    • Withholding proven treatment in clinical research
    • Huston P, Peterson R. Withholding proven treatment in clinical research. New Engl J Med. 2001;345:912-914.
    • (2001) New Engl J Med , vol.345 , pp. 912-914
    • Huston, P.1    Peterson, R.2
  • 6
    • 0034687076 scopus 로고    scopus 로고
    • Placebo-controlled trials and active-control trials in the evaluation of new treatments - Part 2: Practical issues and specific cases
    • Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments - part 2: practical issues and specific cases. Ann Intern Med. 2000; 133:464-470.
    • (2000) Ann Intern Med , vol.133 , pp. 464-470
    • Ellenberg, S.S.1    Temple, R.2
  • 7
    • 0035922438 scopus 로고    scopus 로고
    • The ethics of placebo-controlled trials: A middle ground
    • Emanuel EJ, Miller FG. The ethics of placebo-controlled trials: a middle ground. New Engl J Med 2001;345: 915-919.
    • (2001) New Engl J Med , vol.345 , pp. 915-919
    • Emanuel, E.J.1    Miller, F.G.2
  • 8
    • 0037023023 scopus 로고    scopus 로고
    • Canada to reconsider ethics of placebo-controlled trials
    • Sibbald B. Canada to reconsider ethics of placebo-controlled trials. Can Med Assoc J. 2002;166:641.
    • (2002) Can Med Assoc J , vol.166 , pp. 641
    • Sibbald, B.1
  • 9
    • 0037312999 scopus 로고    scopus 로고
    • The Declaration of Helsinki and clinical trials: A focus on placebo-controlled trials in schizophrenia
    • Carpenter WT, Appelbaum PS, Levine RJ. The Declaration of Helsinki and clinical trials: a focus on placebo-controlled trials in schizophrenia. Am J Psychiatry. 2003;160: 356-362.
    • (2003) Am J Psychiatry , vol.160 , pp. 356-362
    • Carpenter, W.T.1    Appelbaum, P.S.2    Levine, R.J.3
  • 11
    • 0026040246 scopus 로고
    • Neuroleptics and the natural course of schizophrenia
    • Wyatt RJ. Neuroleptics and the natural course of schizophrenia. Schizophr Bull. 1991;17:325-351.
    • (1991) Schizophr Bull , vol.17 , pp. 325-351
    • Wyatt, R.J.1
  • 12
    • 0026777882 scopus 로고
    • Research on first episode psychosis: Report on a National Institute of Mental Health workshop
    • Kirch DG, Keith SJ, Matthews SM. Research on first episode psychosis: report on a National Institute of Mental Health workshop. Schizophr Bull. 1992;18:179-184.
    • (1992) Schizophr Bull , vol.18 , pp. 179-184
    • Kirch, D.G.1    Keith, S.J.2    Matthews, S.M.3
  • 14
    • 0035234392 scopus 로고    scopus 로고
    • Meta-analysis: Recent developments in quantitative methods for literature reviews
    • Rosenthal R, DiMatteo MR. Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol. 2001;52:59-82.
    • (2001) Annu Rev Psychol , vol.52 , pp. 59-82
    • Rosenthal, R.1    DiMatteo, M.R.2
  • 17
    • 5044233596 scopus 로고    scopus 로고
    • Alderson P, Green S, Higgins JPT, eds. Chichester, UK: John Wiley and Sons
    • Alderson P, Green S, Higgins JPT, eds. Cochrane Reviewers' Handbook 4.2.2. Chichester, UK: John Wiley and Sons 2004.
    • (2004) Cochrane Reviewers' Handbook 4.2.2
  • 18
    • 0018189883 scopus 로고
    • Are there schizophrenics for whom drugs may be unnecessary or contraindicated?
    • Rappaport M, Hopkins HK, Hall K, et al. Are there schizophrenics for whom drugs may be unnecessary or contraindicated? Int Pharmacopsychiatry. 1978;13:100-111.
    • (1978) Int Pharmacopsychiatry , vol.13 , pp. 100-111
    • Rappaport, M.1    Hopkins, H.K.2    Hall, K.3
  • 20
    • 0019414614 scopus 로고
    • Schizophrenia: A follow-up study of the results of five forms of treatment
    • May PRA, Tuma AH, Dixon WJ, et al. Schizophrenia: a follow-up study of the results of five forms of treatment. Arch Gen Psychiatry. 1981;38:776-784.
    • (1981) Arch Gen Psychiatry , vol.38 , pp. 776-784
    • May, P.R.A.1    Tuma, A.H.2    Dixon, W.J.3
  • 21
    • 0014057085 scopus 로고
    • One year after discharge: Community adjustment of schizophrenic patients
    • Schooler NR, Goldberg SC, Boothe H, et al. One year after discharge: community adjustment of schizophrenic patients. Am Journal Psychiatry. 1967;123:986-995.
    • (1967) Am Journal Psychiatry , vol.123 , pp. 986-995
    • Schooler, N.R.1    Goldberg, S.C.2    Boothe, H.3
  • 22
    • 0018747456 scopus 로고
    • A non-neuroleptic treatment for schizophrenia: Analysis of the two-year postdischarge risk of relapse
    • Matthews SM, Roper MT, Mosher LR, et al. A non-neuroleptic treatment for schizophrenia: analysis of the two-year postdischarge risk of relapse. Schizophr Bull. 1979;5: 322-333.
    • (1979) Schizophr Bull , vol.5 , pp. 322-333
    • Matthews, S.M.1    Roper, M.T.2    Mosher, L.R.3
  • 23
    • 0027226278 scopus 로고
    • Da pilot-projekt "Soteria Bern" zur behandlung akut schizophener: II. Ergebnisse der vergleichenden prospektiven verlaufsstudie uber 2 jahre
    • Ciompi L, Kupper Z, Aebi E, et al. Da pilot-projekt "Soteria Bern" zur behandlung akut schizophener: II. ergebnisse der vergleichenden prospektiven verlaufsstudie uber 2 jahre [The pilot project "Soteria Bern" for the treatment of acute schizophrenics: II. Results of a comparative prospective study over 2 years]. Der Nervenartz. 1993;64:440-450.
    • (1993) Der Nervenartz , vol.64 , pp. 440-450
    • Ciompi, L.1    Kupper, Z.2    Aebi, E.3
  • 24
    • 0033897147 scopus 로고    scopus 로고
    • Two-year outcome in first-episode psychosis treated according to an integrated model: Is immediate neuroleptisation always needed?
    • Lehtinen V, Aaltonen J, Koffert T, et al. Two-year outcome in first-episode psychosis treated according to an integrated model: is immediate neuroleptisation always needed? Eur Psychiatry. 2000;15:312-320.
    • (2000) Eur Psychiatry , vol.15 , pp. 312-320
    • Lehtinen, V.1    Aaltonen, J.2    Koffert, T.3
  • 25
    • 0037398776 scopus 로고    scopus 로고
    • The treatment of acute psychosis without neuroleptics: Two-year outcomes from the Soteria project
    • Bola JR, Mosher LR. The treatment of acute psychosis without neuroleptics: two-year outcomes from the Soteria project. J Nerv Ment Dis. 2003;191:219-229.
    • (2003) J Nerv Ment Dis , vol.191 , pp. 219-229
    • Bola, J.R.1    Mosher, L.R.2
  • 26
    • 0030942874 scopus 로고    scopus 로고
    • Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: A reanalysis of the Camarillo State Hospital data
    • Wyatt RJ, Green MF, Tuma AH. Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a reanalysis of the Camarillo State Hospital data. Psychol Med. 1997;27:261-268.
    • (1997) Psychol Med , vol.27 , pp. 261-268
    • Wyatt, R.J.1    Green, M.F.2    Tuma, A.H.3
  • 27
    • 0036787134 scopus 로고    scopus 로고
    • One-year outcome in first episode psychosis patients in the Swedish Parachute project
    • Cullberg J, Levander S, Holmquist R, et al. One-year outcome in first episode psychosis patients in the Swedish Parachute project. Acta Psychiatr Scand 2002;106:276-285.
    • (2002) Acta Psychiatr Scand , vol.106 , pp. 276-285
    • Cullberg, J.1    Levander, S.2    Holmquist, R.3
  • 30
    • 0017261735 scopus 로고
    • Schizophrenia - A followup study of results of treatment: I. Design and other problems
    • May PRA, Tuma AH, Dixon WJ. Schizophrenia - a followup study of results of treatment: I. design and other problems. Arch Gen Psychiatry. 1976;33:474-478.
    • (1976) Arch Gen Psychiatry , vol.33 , pp. 474-478
    • May, P.R.A.1    Tuma, A.H.2    Dixon, W.J.3
  • 31
    • 0017231730 scopus 로고
    • Schizophrenia - A follow-up study of results of treatment: II. Hospital stay over two to five years
    • May PRA, Tuma AH, Yale C, et al. Schizophrenia - a follow-up study of results of treatment: II. hospital stay over two to five years. Arch Gen Psychiatry. 1976;33:481-486.
    • (1976) Arch Gen Psychiatry , vol.33 , pp. 481-486
    • May, P.R.A.1    Tuma, A.H.2    Yale, C.3
  • 32
    • 0018173102 scopus 로고
    • Community residential treatment for schizophrenia: Two-year follow-up
    • Mosher LR, Menn AZ. Community residential treatment for schizophrenia: two-year follow-up. Hosp Community Psychiatry. 1978;29:715-723.
    • (1978) Hosp Community Psychiatry , vol.29 , pp. 715-723
    • Mosher, L.R.1    Menn, A.Z.2
  • 33
    • 0029024035 scopus 로고
    • The treatment of acute psychosis without neuroleptics: Six week psychopathology outcome data from the Soteria project
    • Mosher LR, Vallone R, Menn A. The treatment of acute psychosis without neuroleptics: six week psychopathology outcome data from the Soteria project. Int J Soc Psychiatry. 1995;41:157-173.
    • (1995) Int J Soc Psychiatry , vol.41 , pp. 157-173
    • Mosher, L.R.1    Vallone, R.2    Menn, A.3
  • 34
    • 0026706102 scopus 로고
    • The pilot project "Soteria Bern": Clinical experiences and results
    • Ciompi L, Duwalder H-P, Maier C, et al. The pilot project "Soteria Bern": clinical experiences and results. Br J Psychiatry. 1992;161(Suppl 18):145-153.
    • (1992) Br J Psychiatry , vol.161 , Issue.18 SUPPL. , pp. 145-153
    • Ciompi, L.1    Duwalder, H.-P.2    Maier, C.3
  • 35
    • 0027855008 scopus 로고
    • Publication bias: The problem that won't go away
    • Dickersin K, Min YI. Publication bias: the problem that won't go away. Ann N Y Acad Sci. 1993;703:135-146.
    • (1993) Ann N Y Acad Sci , vol.703 , pp. 135-146
    • Dickersin, K.1    Min, Y.I.2
  • 36
    • 0034598111 scopus 로고    scopus 로고
    • Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis
    • Geddes J, Freemantle N, Harrison P, et al. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000;321:1371-1376.
    • (2000) BMJ , vol.321 , pp. 1371-1376
    • Geddes, J.1    Freemantle, N.2    Harrison, P.3
  • 37
    • 0038185229 scopus 로고    scopus 로고
    • Predicting drug-free treatment response in acute psychosis from the Soteria project
    • Bola JR, Mosher LR. Predicting drug-free treatment response in acute psychosis from the Soteria project. Schizophr Bull. 2002;28:559-575.
    • (2002) Schizophr Bull , vol.28 , pp. 559-575
    • Bola, J.R.1    Mosher, L.R.2
  • 38
    • 0038327563 scopus 로고    scopus 로고
    • Clashing ideologies or scientific discourse?
    • Bola JR, Mosher LR. Clashing ideologies or scientific discourse? Schizophr Bull. 2002;28:583-588.
    • (2002) Schizophr Bull , vol.28 , pp. 583-588
    • Bola, J.R.1    Mosher, L.R.2
  • 39
    • 0035062134 scopus 로고    scopus 로고
    • A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic
    • Malla AK, Norman RM, Scholten DJ, et al. A comparison of long-term outcome in first-episode schizophrenia following treatment with risperidone or a typical antipsychotic. J Clin Psychiatry. 2001;62:179-184.
    • (2001) J Clin Psychiatry , vol.62 , pp. 179-184
    • Malla, A.K.1    Norman, R.M.2    Scholten, D.J.3
  • 40
    • 4043128082 scopus 로고    scopus 로고
    • Pharmacological long-term treatment strategies in first-episode schizophrenia: Study design and preliminary results of an ongoing RCT within the German Research Network on schizophrenia
    • Gaebel W, Moller HJ, Buchkremer G, et al. Pharmacological long-term treatment strategies in first-episode schizophrenia: study design and preliminary results of an ongoing RCT within the German Research Network on schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2004;254:129-140.
    • (2004) Eur Arch Psychiatry Clin Neurosci , vol.254 , pp. 129-140
    • Gaebel, W.1    Moller, H.J.2    Buchkremer, G.3
  • 41
    • 33645222572 scopus 로고    scopus 로고
    • New generation antipsychotics for first-episode schizophrenia: Review
    • Rummel C, Harmann J, Kissling W, et al. New generation antipsychotics for first-episode schizophrenia: review. Cochrane Database Syst Rev. 2004;3.
    • (2004) Cochrane Database Syst Rev , vol.3
    • Rummel, C.1    Harmann, J.2    Kissling, W.3
  • 42
    • 0042882529 scopus 로고    scopus 로고
    • Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: A randomized, double-blind trial of olanzepine versus haldol
    • Lieberman JA, Tollefson G, Tohen M, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzepine versus haldol. Am J Psychiatry. 2003; 160:1396-1404.
    • (2003) Am J Psychiatry , vol.160 , pp. 1396-1404
    • Lieberman, J.A.1    Tollefson, G.2    Tohen, M.3
  • 43
    • 2942565924 scopus 로고    scopus 로고
    • Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzepine versus low doses of haloperidol
    • Keefe RS, Seidman LJ, Christensen BK, et al. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzepine versus low doses of haloperidol. Am J Psychiatry. 2004;161:985-995.
    • (2004) Am J Psychiatry , vol.161 , pp. 985-995
    • Keefe, R.S.1    Seidman, L.J.2    Christensen, B.K.3
  • 44
    • 21044457943 scopus 로고    scopus 로고
    • Risperidone and haloperidol in first-episode psychosis: A long-term randomized trial
    • Schooler N, Rabinowitz J, Davidson M, et al. Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. Am J Psychiatry. 2005;162:947-953.
    • (2005) Am J Psychiatry , vol.162 , pp. 947-953
    • Schooler, N.1    Rabinowitz, J.2    Davidson, M.3
  • 45
    • 25144456112 scopus 로고    scopus 로고
    • Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
    • Lieberman JA, Stroup TS, McEvoy JP, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New Engl J Med. 2005;353:1209-1223.
    • (2005) New Engl J Med , vol.353 , pp. 1209-1223
    • Lieberman, J.A.1    Stroup, T.S.2    McEvoy, J.P.3
  • 46
    • 84936424578 scopus 로고
    • Meta-analysis of the effects of practice with the chronically mentally ill: A critique and reappraisal of the literature
    • Hogarty GE. Meta-analysis of the effects of practice with the chronically mentally ill: a critique and reappraisal of the literature. Soc Work. 1989;34:363-373.
    • (1989) Soc Work , vol.34 , pp. 363-373
    • Hogarty, G.E.1
  • 47
    • 0033759914 scopus 로고    scopus 로고
    • Delayed detection of psychosis: Causes, consequences, and effect on public health
    • Lieberman JA, Fenton WS. Delayed detection of psychosis: causes, consequences, and effect on public health. Am J Psychiatry. 2000;157:1727-1730.
    • (2000) Am J Psychiatry , vol.157 , pp. 1727-1730
    • Lieberman, J.A.1    Fenton, W.S.2
  • 48
    • 0032868705 scopus 로고    scopus 로고
    • Does a four-week delay in the introduction of medication alter the course of functional psychosis?
    • Johnstone EC, Owens DG, Crow TJ, et al. Does a four-week delay in the introduction of medication alter the course of functional psychosis? J Psychopharmacol 1999;13: 238-244.
    • (1999) J Psychopharmacol , vol.13 , pp. 238-244
    • Johnstone, E.C.1    Owens, D.G.2    Crow, T.J.3
  • 49
    • 0033756356 scopus 로고    scopus 로고
    • Determinants of neurological dysfunction in first episode schizophrenia
    • Browne S, Clarke M, Gervin M, et al. Determinants of neurological dysfunction in first episode schizophrenia. Psychol Med. 2000;30:1433-1441.
    • (2000) Psychol Med , vol.30 , pp. 1433-1441
    • Browne, S.1    Clarke, M.2    Gervin, M.3
  • 50
    • 0035070861 scopus 로고    scopus 로고
    • Duration of untreated psychosis: A critical examination of the concept and its importance
    • Norman RMG, Malla AK. Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med. 2001;31:381-400.
    • (2001) Psychol Med , vol.31 , pp. 381-400
    • Norman, R.M.G.1    Malla, A.K.2
  • 51
    • 0037712923 scopus 로고    scopus 로고
    • Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: A 52-week randomized trial of clozapine vs chlorpromazine
    • Lieberman JA, Phillips M, Gu H, et al. Atypical and conventional antipsychotic drugs in treatment-naive first-episode schizophrenia: a 52-week randomized trial of clozapine vs chlorpromazine. Neuropsychopharmacology. 2003;28: 995-1003.
    • (2003) Neuropsychopharmacology , vol.28 , pp. 995-1003
    • Lieberman, J.A.1    Phillips, M.2    Gu, H.3
  • 52
    • 0035942011 scopus 로고    scopus 로고
    • Long delays in seeking treatment for schizophrenia
    • Ho BC, Andreasen NC. Long delays in seeking treatment for schizophrenia. Lancet. 2001;357:898-900.
    • (2001) Lancet , vol.357 , pp. 898-900
    • Ho, B.C.1    Andreasen, N.C.2
  • 53
    • 0035694716 scopus 로고    scopus 로고
    • The prevention of schizophrenia: What interventions are safe and effective?
    • Warner R. The prevention of schizophrenia: what interventions are safe and effective? Schizophr Bull. 2001;27: 551-562.
    • (2001) Schizophr Bull , vol.27 , pp. 551-562
    • Warner, R.1
  • 54
    • 0036787553 scopus 로고    scopus 로고
    • Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain
    • Kalla O, Aaltonen J, Wahlstrom J, et al. Duration of untreated psychosis and its correlates in first-episode psychosis in Finland and Spain. Acta Psychiatr Scand. 2002;106: 265-275.
    • (2002) Acta Psychiatr Scand , vol.106 , pp. 265-275
    • Kalla, O.1    Aaltonen, J.2    Wahlstrom, J.3
  • 55
    • 0036536564 scopus 로고    scopus 로고
    • Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia
    • Amminger GP, Edwards J, Brewer WJ, et al. Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia. Schizophr Res. 2002;54:223-230.
    • (2002) Schizophr Res , vol.54 , pp. 223-230
    • Amminger, G.P.1    Edwards, J.2    Brewer, W.J.3
  • 56
    • 0034777062 scopus 로고    scopus 로고
    • Duration of untreated psychosis and cognitive functioning in first-episode patients
    • Norman RMG, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. Br J Psychiatry. 2001;179:340-345.
    • (2001) Br J Psychiatry , vol.179 , pp. 340-345
    • Norman, R.M.G.1    Townsend, L.2    Malla, A.K.3
  • 57
    • 0033826317 scopus 로고    scopus 로고
    • West London first-episode study of schizophrenia: Clinical correlates of duration of untreated psychosis
    • Barnes TRE, Hutton SB, Chapman MJ, et al. West London first-episode study of schizophrenia: clinical correlates of duration of untreated psychosis. Br J Psychiatry. 2000;177: 207-211.
    • (2000) Br J Psychiatry , vol.177 , pp. 207-211
    • Barnes, T.R.E.1    Hutton, S.B.2    Chapman, M.J.3
  • 58
    • 1542313965 scopus 로고    scopus 로고
    • Neurocognitive dysfunction in first-episode psychosis: Correlates with symptoms, premorbid adjustment, and duration of untreated psychosis
    • Rund BR, Melle I, Friis S, et al. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am J Psychiatry. 2004;161:466-472.
    • (2004) Am J Psychiatry , vol.161 , pp. 466-472
    • Rund, B.R.1    Melle, I.2    Friis, S.3
  • 59
    • 0033766996 scopus 로고    scopus 로고
    • Lack of association between duration of untreated psychosis and structural brain deficits at the first episode of schizophrenia
    • Hoff AL, Sakuma M, Razi K, et al. Lack of association between duration of untreated psychosis and structural brain deficits at the first episode of schizophrenia. Am J Psychiatry. 2000;157:1824-1828.
    • (2000) Am J Psychiatry , vol.157 , pp. 1824-1828
    • Hoff, A.L.1    Sakuma, M.2    Razi, K.3
  • 60
    • 0037223895 scopus 로고    scopus 로고
    • Untreated initial psychosis: Relation to cognitive deficits and brain morphology in first-episode schizophrenia
    • Ho B-C, Alicata D, Ward J, et al. Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia. Am J Psychiatry. 2003;160: 142-148.
    • (2003) Am J Psychiatry , vol.160 , pp. 142-148
    • Ho, B.-C.1    Alicata, D.2    Ward, J.3
  • 61
    • 4644336755 scopus 로고    scopus 로고
    • Does duration of untreated psychosis bias study samples of first-episode psychosis?
    • Friis S, Melle I, Larsen TK, et al. Does duration of untreated psychosis bias study samples of first-episode psychosis? Acta Psychiatr Scand. 2004;110:286-291.
    • (2004) Acta Psychiatr Scand , vol.110 , pp. 286-291
    • Friis, S.1    Melle, I.2    Larsen, T.K.3
  • 62
    • 0028916857 scopus 로고
    • Neuroleptic withdrawal in schizophrenic patients: A review of the literature
    • Gilbert PL, Harris MJ, McAdams LA, Jeste DV. Neuroleptic withdrawal in schizophrenic patients: a review of the literature. Arch Gen Psychiatry. 1995;52:173-188.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 173-188
    • Gilbert, P.L.1    Harris, M.J.2    McAdams, L.A.3    Jeste, D.V.4
  • 63
    • 0022543129 scopus 로고
    • Does short-term placebo treatment of chronic schizophrenia produce long-term harm?
    • Curson DA, Hirsch SR, Platt SD, et al. Does short-term placebo treatment of chronic schizophrenia produce long-term harm? BMJ. 1986;293:726-728.
    • (1986) BMJ , vol.293 , pp. 726-728
    • Curson, D.A.1    Hirsch, S.R.2    Platt, S.D.3
  • 64
    • 0029262981 scopus 로고
    • Why neuroleptic withdrawal in schizophrenia?
    • Carpenter WT, Tamminga CA. Why neuroleptic withdrawal in schizophrenia? Arch Gen Psychiatry. 1995;52:192-193.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 192-193
    • Carpenter, W.T.1    Tamminga, C.A.2
  • 65
    • 0026042050 scopus 로고
    • Maintenance medication for schizophrenia: Strategies for dose reduction
    • Schooler NR. Maintenance medication for schizophrenia: strategies for dose reduction. Schizophr Bull. 1991;17: 311-324.
    • (1991) Schizophr Bull , vol.17 , pp. 311-324
    • Schooler, N.R.1
  • 66
    • 0029264053 scopus 로고
    • Neuroleptic withdrawal in schizophrenic patients
    • Baldessarini RJ, Viguera AC. Neuroleptic withdrawal in schizophrenic patients. Arch Gen Psychiatry. 1995;52: 189-192.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 189-192
    • Baldessarini, R.J.1    Viguera, A.C.2
  • 67
    • 0029263813 scopus 로고
    • Neuroleptic withdrawal in schizophrenic patients: An idea whose time has come
    • Meltzer HY. Neuroleptic withdrawal in schizophrenic patients: an idea whose time has come. Arch Gen Psychiatry. 1995;52:200-202.
    • (1995) Arch Gen Psychiatry , vol.52 , pp. 200-202
    • Meltzer, H.Y.1
  • 68
    • 0037497745 scopus 로고    scopus 로고
    • Medication-free research and patient safety
    • Carpenter WT. Medication-free research and patient safety. Schizophr Bull. 1998;24:35-36.
    • (1998) Schizophr Bull , vol.24 , pp. 35-36
    • Carpenter, W.T.1
  • 69
    • 1842301779 scopus 로고    scopus 로고
    • The rationale and ethics of medication-free research in schizophrenia
    • Carpenter WT, Schooler NR, Kane JM. The rationale and ethics of medication-free research in schizophrenia. Arch Gen Psychiatry. 1997;45:401-407.
    • (1997) Arch Gen Psychiatry , vol.45 , pp. 401-407
    • Carpenter, W.T.1    Schooler, N.R.2    Kane, J.M.3
  • 70
    • 0000446105 scopus 로고
    • Early neuroleptic medication within one year after onset can reduce risk of later relapses in schizophrenic patients
    • Anzai N, Okazaki Y, Miyauchi M, et al. Early neuroleptic medication within one year after onset can reduce risk of later relapses in schizophrenic patients. Annu Rep Pharmacopsychiatr Res Found. 1988;19:258-265.
    • (1988) Annu Rep Pharmacopsychiatr Res Found , vol.19 , pp. 258-265
    • Anzai, N.1    Okazaki, Y.2    Miyauchi, M.3
  • 71
    • 0018050337 scopus 로고
    • A study on the long-term prognosis of schizophrenia under psychotropic medication
    • Aritome T. A study on the long-term prognosis of schizophrenia under psychotropic medication. Jikeikai Med J. 1978; 25:269-286.
    • (1978) Jikeikai Med J , vol.25 , pp. 269-286
    • Aritome, T.1
  • 73
    • 0017429154 scopus 로고
    • The treatment of acute schizophrenia without drugs: An investigation of some current assumptions
    • Carpenter WT, McGlashan TH, Strauss JS. The treatment of acute schizophrenia without drugs: an investigation of some current assumptions. Am J Psychiatry. 1977;134:14-20.
    • (1977) Am J Psychiatry , vol.134 , pp. 14-20
    • Carpenter, W.T.1    McGlashan, T.H.2    Strauss, J.S.3
  • 74
    • 0026507729 scopus 로고
    • The international pilot study of schizophrenia: Five-year follow-up findings
    • Leff J, Sartorius N, Jablensky A, et al. The international pilot study of schizophrenia: five-year follow-up findings. Psychol Med. 1992;22:131-145.
    • (1992) Psychol Med , vol.22 , pp. 131-145
    • Leff, J.1    Sartorius, N.2    Jablensky, A.3
  • 75
    • 0022668286 scopus 로고
    • The Northwick Park study of first episodes of schizophrenia: II. A randomised controlled trial of prophylactic neuroleptic treatment
    • Crow TJ, Jones BD, Anable AL, et al. The Northwick Park study of first episodes of schizophrenia: II. a randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry. 1986;148:120-127.
    • (1986) Br J Psychiatry , vol.148 , pp. 120-127
    • Crow, T.J.1    Jones, B.D.2    Anable, A.L.3
  • 76
    • 0021909580 scopus 로고
    • Long-term depot maintenance of chronic schizophrenic outpatients: The seven-year follow-up of the medical research council fluphenazine/placebo trial
    • Curson DA, Barnes TR, Bamber RW, et al. Long-term depot maintenance of chronic schizophrenic outpatients: the seven-year follow-up of the medical research council fluphenazine/placebo trial. Br J Psychiatry. 1985;146:464-480.
    • (1985) Br J Psychiatry , vol.146 , pp. 464-480
    • Curson, D.A.1    Barnes, T.R.2    Bamber, R.W.3
  • 78
    • 0019200123 scopus 로고
    • Longitudinal studies of schizophrenic patients
    • Huber G, Gross G, Schuttler R, et al. Longitudinal studies of schizophrenic patients. Schizophr Bull 1980;6:592-605.
    • (1980) Schizophr Bull , vol.6 , pp. 592-605
    • Huber, G.1    Gross, G.2    Schuttler, R.3
  • 79
    • 0020595658 scopus 로고
    • The discontinuance of maintenance therapy in chronic schizophrenic patients: Drug and social consequences
    • Johnson DAW, Pasterski G, Ludlow JM, et al. The discontinuance of maintenance therapy in chronic schizophrenic patients: drug and social consequences. Acta Psychiatr Scand. 1983;67:339-352.
    • (1983) Acta Psychiatr Scand , vol.67 , pp. 339-352
    • Johnson, D.A.W.1    Pasterski, G.2    Ludlow, J.M.3
  • 80
    • 0001611013 scopus 로고
    • Outcomes of treatment of schizophrenia in a northeast Scottish hospital
    • McWalter HS, Mercer R, Sutherland MM, et al. Outcomes of treatment of schizophrenia in a northeast Scottish hospital. Am J Psychiatry. 1961;118:529-533.
    • (1961) Am J Psychiatry , vol.118 , pp. 529-533
    • McWalter, H.S.1    Mercer, R.2    Sutherland, M.M.3
  • 81
    • 0015102144 scopus 로고
    • Changes in clinical course and symptomatology of schizophrenia following introduction of pharmacotherapy
    • Murakami K. Changes in clinical course and symptomatology of schizophrenia following introduction of pharmacotherapy [in Japanese]. Psychatria et Neurologia Japonica. 1971;73:635-649.
    • (1971) Psychatria et Neurologia Japonica , vol.73 , pp. 635-649
    • Murakami, K.1
  • 82
    • 0000186429 scopus 로고
    • Pattern of discharge from Norwegian psychiatric hospitals before and after the introduction of psychotropic drugs
    • Odegard O. Pattern of discharge from Norwegian psychiatric hospitals before and after the introduction of psychotropic drugs. Am J Psychiatry. 1964;120:772-778.
    • (1964) Am J Psychiatry , vol.120 , pp. 772-778
    • Odegard, O.1
  • 83
    • 0000741593 scopus 로고
    • First admitted schizophrenics in drug era
    • Peterson DB, Olson GW. First admitted schizophrenics in drug era. Arch Gen Psychiatry. 1964;11:137-144.
    • (1964) Arch Gen Psychiatry , vol.11 , pp. 137-144
    • Peterson, D.B.1    Olson, G.W.2
  • 84
    • 0014174485 scopus 로고
    • Prognosis of schizophrenia before and after pharmacotherapy: I. Short-term outcome
    • Pritchard DM. Prognosis of schizophrenia before and after pharmacotherapy: I. short-term outcome. Br J Psychiatry. 1967;113:1345-1352.
    • (1967) Br J Psychiatry , vol.113 , pp. 1345-1352
    • Pritchard, D.M.1
  • 85
    • 0014178834 scopus 로고
    • Prognosis of schizophrenia before and after pharmacotherapy: II. Three-year follow-up
    • Pritchard DM. Prognosis of schizophrenia before and after pharmacotherapy: II. three-year follow-up. Br J Psychiatry. 1967;113:1353-1359.
    • (1967) Br J Psychiatry , vol.113 , pp. 1353-1359
    • Pritchard, D.M.1
  • 86
    • 9244226681 scopus 로고
    • The influence of the drug therapy on the prognosis of schizophrenia
    • Shimanzono Y, Toru H. The influence of the drug therapy on the prognosis of schizophrenia [in Japanese]. Seishin Igaku. 1968;19:157-162.
    • (1968) Seishin Igaku , vol.19 , pp. 157-162
    • Shimanzono, Y.1    Toru, H.2
  • 87
    • 0020965183 scopus 로고
    • The natural history of schizophrenia: A 5-year prospective follow-up of a representative sample of schizophrenics by means of standardized clinical and social assessment
    • Watt DC, Katz K, Shepherd M. The natural history of schizophrenia: a 5-year prospective follow-up of a representative sample of schizophrenics by means of standardized clinical and social assessment. Psychol Med. 1983;13:663-670.
    • (1983) Psychol Med , vol.13 , pp. 663-670
    • Watt, D.C.1    Katz, K.2    Shepherd, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.